pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Aug 11·1 min read
save

Abortion care shifts to remote and private channels as patients seek help outside clinics

Aug 11, 2026·read at STAT ↗Neutral

Patients are increasingly turning to non‑clinical avenues for abortion information, a trend that began before the Dobbs decision. A family physician recounts a recent encrypted message from a teenager who had taken misoprostol and needed confidential guidance without parental involvement.

A new study published in The Lancet Regional Health Americas examined more than 16,000 contacts with a Miscarriage + Abortion Hotline over a two‑year period. The analysis revealed a growing reliance on phone and online resources for advice and support, indicating that many people prefer discreet, remote options.

These findings suggest a broader transformation in how abortion care is delivered in the United States. As legal and social pressures intensify, patients are seeking private, digital, and telehealth solutions to manage their reproductive health safely and anonymously.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: The new geography of abortion care”

read at STAT ↗
1,182 words · retrieved Aug 11
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

drugs
misoprostol2
topics
GLP-1 receptorObesityPain

related stories

  • 1d agoNovo struggles to appease restive investors with consumer plans, blockbuster ambitionsFierce Biotech
  • 1d agoAre healthcare systems really ready for GLP-1s?BioPharma Dive
  • 4d agoArtelo’s ex-AstraZeneca cannabinoid agonist holds its own against GLP-1 drug semaglutide in obese miceFierce Biotech
  • Sep 2Beyond GLP‑1s: The race for next‑gen obesity drugs starts in the preclinical modelsBioSpace
  • Aug 31New guidelines on migraine prevention reflect increasing options for patientsSTAT